key: cord-0040557-ny86bv95 authors: Tebruegge, Marc; Curtis, Nigel title: Infections of the Upper and Middle Airways date: 2017-07-18 journal: Principles and Practice of Pediatric Infectious Diseases DOI: 10.1016/b978-0-323-40181-4.00028-1 sha: 7af71557026518d0a46748ea67380ca947b11713 doc_id: 40557 cord_uid: ny86bv95 nan torticollis. d Trismus is uncommon, but drooling can occur. Most patients have evidence of pharyngitis or tonsillitis and cervical lymphadenitis on examination. 44, 52 In most reports, the proportion of patients with symptoms that indicate airway obstruction, such as difficulty in breathing and stridor, is relatively small. 41, [43] [44] [45] [46] 50, 52 Airway obstruction in the context of retropharyngeal abscess predominately occurs in infants and very young children. [41] [42] [43] Peripheral blood leukocytosis is common. e The CRP level and erythrocyte sedimentation rate (ESR) usually are elevated. 49, 52 In most cases, enlargement of the retropharyngeal space/prevertebral tissue can be seen incidence of retropharyngeal abscess has increased over the past decade. 38, 41, 43, 49 Similar observations have been reported from the UK. 55 Retropharyngeal abscess in children predominately results from infection and suppuration of the retropharyngeal chains of lymph nodes, which drain the nasopharynx, the paranasal sinuses, and the adenoids. 38, [40] [41] [42] [43] 46 Common primary infections include pharyngitis, tonsillitis, adenitis, and less frequently, sinusitis, otitis media, mastoiditis, and dental infections. Unlike in adults, local trauma and foreign body ingestion play a relatively minor role in children. c Clinical Manifestations and Differential Diagnosis. Common presenting features include pyrexia, sore throat, dysphagia, odynophagia, neck pain, neck swelling, limited neck mobility (particularly on extension), and PART II Clinical Syndromes and Cardinal Features of Infectious Diseases: Approach to Diagnosis and Initial Management performed using the transoral approach and less commonly using the transcervical route. i Complications and Prognosis. Potential complications include airway obstruction, internal jugular vein thrombosis, mycotic aneurysm of the carotid artery, aspiration pneumonia, mediastinitis, and sepsis, although these are rare overall. j Few patients require repeated surgical intervention. 43, 45, 49 Most patients have an uncomplicated course and can be discharged on oral antibiotics within a few days. 41, 42 Fatal outcomes have been rare in recent studies. The lateral pharyngeal space (i.e., parapharyngeal space) is shaped like an inverted cone extending from the base of the skull to the hyoid bone. It is bound medially by the superior pharyngeal constrictor muscle and laterally by the internal pterygoid muscle. 69 The lateral pharyngeal space contains the internal carotid artery, the internal jugular vein, cranial nerves IX to XII, the sympathetic chain, and the lymph nodes. This space is separated from the retropharyngeal space by only the alar fascia, which provides little barrier against the spread of infection. 69 Simultaneous infection of both compartments is common, and some investigators on plain lateral neck radiographs ( Fig. 28.1) . 38, 43, 44, 56 However, CT is more sensitive and is the imaging modality of choice. 43, 45, 50, [56] [57] [58] [59] [60] [61] [62] Management. There is no consensus about the optimal empiric antibiotic treatment. Penicillin or ampicillin alone is insufficient because β-lactamase-producing organisms, S. aureus, and mixed infections are common. Appropriate empiric antibiotic regimens include a second-or third-generation cephalosporin plus clindamycin or metronidazole, amoxicillin-clavulanate, ampicillin-sulbactam, and piperacillintazobactam. f Some physicians think that clindamycin alone may be sufficient. 40, 54 Local patterns of susceptibility of S. aureus and the clinical state of the patient should be taken into account, frequently leading to a combination of antibiotics that includes clindamycin or vancomycin. 49 The role of surgical drainage remains controversial. g Patients with significant respiratory distress require urgent airway management and surgical drainage. However, there is debate about whether a trial of conservative management with intravenous antibiotics for a 24-to 48-hour period in conjunction with close monitoring is appropriate for patients who are stable and have no respiratory distress. 38, [44] [45] [46] 50 The reported success rates with conservative management alone vary considerably between studies, and there have been no randomized trials. h Surgical drainage usually is There appears to be male predominance. 87, 101 Most cases have no predisposing illness. In most cases, the disease process begins with a primary focus of infection in the oropharynx (e.g., palatine tonsils, peritonsillar tissue). Other infections in the head and neck area, including sinusitis, otitis, mastoiditis, parotitis, and odontogenic infections, are less common sources. p The infection subsequently spreads to the lateral pharyngeal space or parapharyngeal space. Further progression results in infectious thrombophlebitis of the internal jugular vein, which causes septic pulmonary emboli and metastatic infection at other distant sites. The lungs are the most commonly involved secondary site, followed by joint and soft tissue infections, 87, 88, 95, 101 Other manifestations, such as skin infection, osteomyelitis, liver abscess, splenic abscess, and meningitis, are rare. 87, 91, 101, [104] [105] [106] [107] Clinical Manifestations and Differential Diagnosis. The presenting features of Lemierre syndrome depend partly on the primary site of infection. Most cases are diagnosed within 7 days of onset of the primary infection. 87 In patients with an oropharyngeal source, inspection may reveal exudative tonsillitis, hyperemia, or grayish pseudomembranes. An unremarkable oropharyngeal appearance at the time of septicemia does not rule out Lemierre syndrome. 87, 108 Patients with otitis media or mastoiditis as the primary focus can have otorrhea or postauricular fluctuation. 91, 109 Most patients have high-grade pyrexia (>39.5°C) at presentation, although fever can be absent. Neck swelling and tenderness is seen in most cases. Other symptoms and signs include trismus, dysphagia, dyspnea, hemoptysis, pleuritic chest pain, nausea and vomiting, jaundice, hepatomegaly, and hypotension. Severe shock and renal failure are uncommon despite the septicemic state. 87, 94 Auscultation and percussion of the chest may reveal crepitations and evidence of pleural effusions in cases with pulmonary involvement. The WBC count, CRP, and ESR often are markedly elevated. q Thrombocytopenia occurs in approximately a quarter of patients. 110 Levels of liver enzymes and bilirubin are sometimes not elevated. 87, 95 Blood cultures typically are positive, but they may be sterile in patients who have taken antibiotics before samples were collected for culture. Contrast-enhanced CT of the neck is the most useful investigation. Possible CT findings include distended neck veins, intraluminal filling defects, and soft tissue swelling. 95, 100, 111, 113, 114 Doppler ultrasonography and magnetic resonance imaging are also useful in this setting. The chest radiograph and chest CT may reveal pulmonary infiltrates, pulmonary cavitation, or pleural effusions ( Fig. 28 . Management. Antibiotic treatment is the mainstay of therapy. Common empiric regimens include high-dose penicillin with metronidazole, clindamycin, ticarcillin-clavulanate, and ampicillin-sulbactam. r Due to the endovascular nature of the infection, intravenous therapy is required for several weeks. Surgical debridement of necrotic tissues and drainage of abscess or empyema often are required in conjunction with medical therapy. Ligation or resection of the internal jugular vein was a common therapeutic intervention in the preantibiotic era. However, this is rarely necessary and should be restricted to unstable patients who fail to respond to conservative therapy. 98, 110, 111, 116 The role of routine anticoagulation therapy in Lemierre syndrome continues to be controversial. s Complications and Prognosis. Metastatic infections can cause complications depending on their location. Pleural effusions, empyema, lung abscesses, and pulmonary cavitation can occur in patients with Lemierre syndrome. Pneumatocele and pneumothorax can occur. Septic pyogenic arthritis typically affects larger joints, such as the shoulder, elbow, and hip joints (see Fig. 28 .2). 87, 101 Renal involvement can be associated with proteinuria or hematuria. In the preantibiotic era, the prognosis was poor, with fatality rates as high as 90% in some historical reports. 86, 102 Recent reviews of the literature suggest that fatal outcomes are uncommon, typically between 5% and 10%. 87, 88 think that a distinction between parapharyngeal and retropharyngeal abscess is not meaningful clinically. 46, 65, [69] [70] [71] Etiologic Agents, Epidemiology, and Pathogenesis. The spectrum and frequency of causative organisms are similar to those reported for retropharyngeal abscess. 30, 72 Studies of deep neck space infections in children suggest that parapharyngeal abscesses are less common than retropharyngeal abscesses. 7, 31, 45, 52 Unlike retropharyngeal abscess, parapharyngeal abscess occurs in all age groups without a predilection for younger children. 51, 73 Parapharyngeal abscess is thought to result primarily from infection and subsequent suppuration of lymph nodes in the lateral pharyngeal space, which are part of the lymphatic drainage of the nasopharynx and middle ear. [73] [74] [75] [76] In many cases, there is a history of preceding pharyngitis or tonsillitis. Clinical Manifestations and Differential Diagnosis. The clinical features of parapharyngeal abscess closely resemble those associated with retropharyngeal abscess. 69 Fever and neck swelling are common; patients also can have dysphagia, odynophagia, torticollis, or trismus. k A common feature distinguishing parapharyngeal abscess from retropharyngeal abscess is deviation of the lateral wall of the oropharynx to the midline on oral inspection. 73, [77] [78] [79] Peripheral blood leukocytosis and an elevated CRP level are common. 66, 74 Contrast-enhanced CT is the imaging modality of choice for investigating suspected cases. l Plain lateral neck radiographs are not useful. 45 Management, Complications, and Prognosis. Management of parapharyngeal abscess is similar to that for retropharyngeal abscess. There is ongoing controversy among experts about whether surgery is mandatory in all patients. m Traditionally, an external cervical approach has been used for the drainage of parapharyngeal abscesses, 7,60,81 but transoral drainage has been reported to be safe and effective in selected cases with abscess location medial to the great vessels. 69, 71, 76, 77, 81 The transoral approach has cosmetic advantages, and the intraoperative time usually is shorter. 81 Potential complications comprise internal jugular vein thrombosis, erosion of the carotid artery, airway obstruction, aspiration pneumonia, pleural empyema, mediastinitis, pericarditis, and septic shock. n Fatal outcomes and long-term sequelae are rare. 31, 70, 73 The first description of Lemierre syndrome was published in 1900 by Courmont and Cade, 84 followed by a report by Schottmüller in 1918. 85 The clinical syndrome, also referred to as necrobacillosis, is named in honor of André Lemierre, who described a series of 20 cases of "postanginal septicemia" in 1920. 86 Lemierre syndrome is characterized by primary infection of the oropharynx, blood culture-confirmed septicemia, evidence of thrombophlebitis of the internal jugular vein, and metastatic infection at one or more distant sites. 87 Etiologic Agents. Fusobacterium necrophorum is by far the most commonly implicated etiologic agent in cases of Lemierre syndrome. 87-90 F. necrophorum is an obligate anaerobic, gram-negative bacillus that is part of the normal flora of the oral cavity and the gastrointestinal and female genital tract. Most strains are susceptible to second-and third-generation cephalosporins, clindamycin, and metronidazole; a significant proportion of clinical isolates produce β-lactamase. [91] [92] [93] Other causative bacteria associated with Lemierre syndrome include other Fusobacterium species, Bacteroides species, Prevotella species, streptococci (mainly non-group A), and infrequently staphylococci. 87, 88, 90, [94] [95] [96] Mixed infections also occur. 89, 95 Epidemiology and Pathogenesis. Despite the absence of solid epidemiologic data, most experts agree that the incidence of the disease declined considerably during the antibiotic era. Lemierre syndrome currently is uncommon, with an estimated annual incidence of approximately 1 case per 1 million people. 97 However, some data suggest that the incidence has increased in recent years. 98 The disease typically affects teenagers and young adults, o although a few cases in infancy have been described. 91 Epidemiology and Pathogenesis. In the pre-Hib vaccination era, the incidence of epiglottitis peaked in early childhood, typically affecting children younger than 4 years of age. 132, 137, 141 After institution of universal Hib vaccination, the peak incidence shifted toward an older age group, with a simultaneous increase in the proportion of adult cases. u Many studies show no sex predominance, while others report some male predominance. 122, 132, [143] [144] [145] There is little seasonal variation in incidence in temperate climates. 129, [143] [144] [145] [146] Acute epiglottitis is a localized, invasive bacterial infection of the supraglottic area, comprising the epiglottis, arytenoid cartilages, aryepiglottic folds, and false vocal chords. Inflammation results in airway edema and narrowing, which leads to airway obstruction manifesting as stridor and respiratory distress. The localized infection can evolve into phlegmon and abscess formation. Bacteremia is common in cases caused by Hib, but dissemination to distant sites (e.g., causing septic arthritis or meningitis) is rare. The incidence of invasive Haemophilus influenzae type b (Hib) disease decreased dramatically, and epiglottitis (i.e., supraglottitis) has become a rare disease in countries where Hib vaccines are used routinely. [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] Data from England and Wales show that the incidence of invasive Hib disease after 2 decades of routine immunization fell to 0.02 cases per 100,000 inhabitants. 130 Necrotizing epiglottitis is a rare variant, which has been reported predominately among immunocompromised patients. 131 Etiologic Agents. Hib infection accounted for approximately 75% to 90% of epiglottitis cases in the pre-Hib vaccination era. 119 controversial, and no RCT has addressed this question. 120, 140, 148 However, previous, uncontrolled studies have not shown a clear benefit regarding the need for intubation, duration of ventilation, or duration of hospital stay. 137, 140, 146 In cases with confirmed Hib epiglottitis, prophylaxis with rifampin should be considered for household contacts according to American Academy of Pediatrics recommendations. 150 The latest UK guidelines also recommend the use of rifampin and suggest ciprofloxacin or azithromycin as an alternative for people who cannot tolerate rifampin or in whom rifampin can interfere with other drugs. 151 Complications and Prognosis. Potential complications include complete airway obstruction and cardiac arrest, epiglottic abscess, deep neck infection, pneumonia, and seizures. 122, 129, 132, 137 Most patients require only a short period of intubation and ventilation and can be extubated in 24 to 72 hours. 122, 129, 132, 145 The mortality rate is less than 5% in settings where good intensive care support is available. 129, 132, 137, 141, 143 CROUP Viral croup (i.e., laryngotracheitis) is the most common cause of infectious upper airway obstruction in young children. Some physicians prefer to divide croup into spasmodic croup and laryngotracheitis, also referred to as laryngotracheobronchitis. 152 However, in the clinical setting, this distinction is not particularly meaningful, and croup is therefore used in this chapter. Etiologic Agents and Epidemiology. Parainfluenza virus types 1, 2, and 3 are the most common causative agents of croup, accounting for 50% to 80% of cases, followed by influenza A, influenza B, and respiratory syncytial virus. [153] [154] [155] [156] [157] [158] [159] Less common etiologic agents include adenoviruses, rhinoviruses, coxsackieviruses, and echoviruses. 153, 154, 158, 160 Studies have associated human metapneumovirus, human bocavirus, and human coronavirus NL63 with croup. [160] [161] [162] [163] [164] [165] [166] [167] Some data suggest that the clinical course of croup caused by influenza virus is more severe than croup caused by parainfluenza virus. 153 Epidemiology and Pathogenesis. Croup is common. One study from Seattle estimated the annual incidence to be as high as 7 cases per 1000 children younger than 6 years of age. 158 The incidence of croup is highest among children between the ages of 6 months and 2 years. 154, [156] [157] [158] Typical croup symptoms are rarely observed in children older than 6 years of age, likely because of the increase in airway diameter. 157 The incidence is higher among boys. [152] [153] [154] 156, 168 In temperate climates, the incidence typically peaks in late autumn and winter. 154, 156, 158, 168, 169 Inflammatory edema and mucus production result in airway narrowing in the subglottic region, resulting in stridor. 147, 152, 170, 171 Inflammation of the vocal chords results in hoarseness and sometimes in aphonia. The typical features of croup are inspiratory stridor, a barking cough, and hoarseness. Symptoms often start abruptly and typically worsen during the night. 172 Nonspecific coryzal symptoms frequently precede the illness. Most patients have low-grade or moderate-grade fever. 155, 156 Less than 3% of cases in a primary care setting require hospitalization. 155, 156 Infectious and noninfectious causes and clinical features of upper airway obstruction, including croup, are delineated in Chapter 21 (see Tables 21.3-21.5). The noninfectious differential diagnosis includes foreign body aspiration, vocal chord dysfunction, laryngeal webs, allergic or hypocalcemic laryngospasm, subglottic stenosis (e.g., after prolonged intubation), tracheomalacia, H-type tracheoesophageal fistula, gastroesophageal reflux, and vascular ring. 153, [172] [173] [174] [175] Laryngeal diphtheria, now a rare but potentially life-threatening infection, can begin as severe croup. 172, 176, 177 The diagnosis of croup is made primarily on clinical grounds. Airway or chest radiographs are not indicated in cases with uncomplicated croup. 172, 178, 179 However, a radiograph showing narrowing of the subglottic airway can be useful if an alternative diagnosis is suspected. Respiratory viral panel testing by PCR can confirm a typical agent but frequently does not aid management. 172 Management. Treatment with mist or humidified air has been a key component of croup management for much of the 20th century, 152 although only a few published RCTs have investigated the effectiveness of humidified air in hospitalized patients. [180] [181] [182] [183] There are no published data on the effectiveness of warm, humidified air in the home environment-a measure frequently recommended to parents. 184 A Clinical Manifestations and Diagnosis. Children with epiglottitis typically look systemically unwell and have high-grade fever and stridor. 122, 137, 145 Aphonia, hoarseness, and a muffled, "hot potato" voice are common features. 129, 137 Odynophagia is common, and drooling frequently is observed. Most patients assume an upright tripod position with forward leaning and extension of the neck. 147 Cervical lymphadenopathy also is a common feature. 137 Peripheral blood leukocytosis is present in most cases. 129, 137, 140, 146 Lateral neck radiographs demonstrate epiglottic enlargement with a distended hypopharynx, a classic thumb sign that has high sensitivity ( Fig. 28.3 ). However, this should be attempted only for a stable, cooperative patient in a safe environment because performing radiography in the lateral position can precipitate respiratory arrest from complete airway obstruction, especially if the child's neck is repositioned for optimal results. 133, 137 Management. Effective airway management is critical. Upsetting the child during attempts to inspect the oropharynx can result in complete airway obstruction. Nebulized epinephrine (i.e., adrenaline) can provide some transient improvement in respiratory distress but also can cause agitation and precipitate airway obstruction. Unstable patients should be urgently intubated by direct laryngoscopy or bronchoscopy in a controlled setting (i.e., operating room or intensive care unit). Although rarely required, facilities to perform a tracheostomy must be available in case attempts to intubate fail. 122, 129, 137, 143 There continues to be controversy about whether cases at the mild end of the disease spectrum without significant respiratory distress can be managed safely without intubation while being closely monitored. 129, 137, 148 Blood cultures and throat or epiglottic swabs (in intubated cases) should be obtained for culture and susceptibility testing. Empiric antibiotic therapy, such as a third-generation cephalosporin or ampicillinsulbactam, should be commenced promptly. v The routine use of corticosteroids, which is intended to reduce airway edema, remains Acute laryngitis in previously healthy people usually is a self-limited viral disease. Treatment with antibiotics is not routinely indicated. A Cochrane review on this topic, which included two RCTs evaluating penicillin V and erythromycin versus placebo, concluded that routine antibiotic treatment has no proven benefit. 215 The term bacterial tracheitis was first used in a publication by Jones and colleagues in 1979. 216 Earlier reports describe cases of laryngotracheobronchitis that closely resemble descriptions of bacterial tracheitis, suggesting that this entity was recognized previously. 217, 218 Etiologic Agents. S. aureus is by far the most common causative organism. 125, [219] [220] [221] Other bacteria commonly implicated in bacterial tracheitis are S. pyogenes, S. pneumoniae, H. influenzae, and M. catarrhalis. Cases attributed to a variety of other bacteria, including Pseudomonas aeruginosa, Bacillus cereus, Escherichia coli, Prevotella species, and Bacteroides species also have been reported, although they appear to be uncommon. [219] [220] [221] [222] [223] [224] [225] [226] Epidemiology and Pathogenesis. Bacterial tracheitis is rare, with an estimated annual incidence below 0.1 case per 100,000 children in the United Kingdom and Australia. 220 Incidence data have not been published for other countries. Some data suggest that the incidence peaks during autumn and winter. 220 Bacterial tracheitis predominately affects young children, although a few adult cases have been described. [227] [228] [229] The pathogenesis of bacterial tracheitis remains unclear. It has been postulated that viral infection of the upper respiratory tract may facilitate secondary bacterial infection and invasion of the airways, resulting in inflammation and edema, which ultimately leads to narrowing of the trachea. 219 The peak incidence of bacterial tracheitis coincides with the peak season for viral respiratory pathogens, suggesting synergy. In one large case series, coinfection with influenza virus was identified in almost one third of the cases. 221 Coinfection with parainfluenza virus, respiratory syncytial virus, or adenovirus has been described in other reports. 125, 220, 223, 230 Clinical Manifestations and Differential Diagnosis. Most patients with bacterial tracheitis report prodromal symptoms suggestive of a minor upper respiratory tract infection, which typically began 2 to 5 days before the onset of stridor. 219, 220 After stridor and dyspnea develop, patients often deteriorate rapidly, frequently requiring intubation within the first 24 hours to overcome increasing upper airway obstruction. 216, 220, [231] [232] [233] Other common features at presentation include fever (often moderate to high grade), hoarse voice or aphonia, cough, and intercostal and subcostal recessions. Drooling is uncommon. Most cases show little or no response to nebulized epinephrine. 234 The main differential diagnoses are epiglottis and viral croup. Unlike cases of bacterial tracheitis, children with epiglottitis typically refuse to speak, have drooling, and adopt an upright position with extension of the neck. Children with croup typically have only low-grade pyrexia, do not appear toxic, and usually respond to nebulized epinephrine. An inflammatory response, including an elevated CRP level and WBC count, is seen in most patients at presentation. 220, 234 The radiograph may demonstrate narrowing of the tracheal air shadow and intraluminal tracheal membranes, although these are not universal findings (Fig. 28.4) . 223, 230 Coexisting pulmonary changes, including infiltrates and atelectases, are common. 220, [234] [235] [236] [237] Direct visualization of the airways reveals an unremarkable or only mildly inflamed epiglottis but shows marked subglottic inflammation, edema of the tracheal mucosa, and copious purulent endotracheal secretions. 216, 234 Endotracheal aspirates should be obtained and sent for bacterial culture and susceptibility testing. Blood cultures are rarely helpful, as bacteremia is relatively uncommon in these patients. Management. Proactive airway management is critical in managing bacterial tracheitis to prevent complete airway obstruction and consequent respiratory arrest. In most of the larger published case series, 80% to 100% of patients required intubation or tracheostomy and mechanical ventilation. Intubation usually is challenging and requires the use of an endotracheal tube of considerably smaller diameter than would be expected based on the patient's age. The personnel and equipment for a tracheostomy must be readily available in case conventional intubation fails. Appropriate empiric antibiotic treatment must include effective antistaphylococcal coverage. A combination of a third-generation Cochrane review that included pooled data from three RCTs found that there was a modest, statistically not significant improvement in the croup severity score of patients receiving humidified air compared with untreated patients during the first hour of treatment; there was no difference between treatment groups for other outcome measures. 184 Treatment with corticosteroids is routinely indicated. 152 A Cochrane review that included 31 RCTs showed that corticosteroid treatment was associated with significant improvement in the croup severity score at 6 and 12 hours compared with placebo. 185 Corticosteroid treatment was associated with a shorter duration of stay in the emergency department or hospital, fewer admissions, and fewer return visits. However, a range of different corticosteroids (e.g., dexamethasone, budesonide, methylprednisolone, fluticasone), different routes of administration (e.g., oral, intramuscular, inhalation), and doses were used in the trials. Most experts recommend the use of oral or intramuscular dexamethasone (0.6 mg/kg) or nebulized budesonide (2 mg). 152, 178, [186] [187] [188] It remains unclear whether repeated doses over the first 48 hours improve outcome. 189 Many studies have shown that nebulized epinephrine is effective for achieving symptomatic improvement in children with moderate to severe croup. [190] [191] [192] [193] [194] [195] Some data suggest that the use of nebulized epinephrine results in a considerable reduction in the need for intubation or tracheostomy. 196 The drug can be administered as racemic epinephrine (2.25%; 0.5 mL in 2.5 mL of saline) or l-epinephrine (1:1000 solution; 5 mL). A 2013 Cochrane review concluded that the two drugs were equally effective. 197 The treatment is safe, and side effects such as pallor and tachycardia usually are mild and transient. 198 For children with moderate croup (i.e., stridor and chest wall indrawing at rest) who fail to improve sufficiently within 4 to 6 hours of administration of a corticosteroid, hospitalization should be considered. Children with severe croup should receive a dose of a corticosteroid and be treated with nebulized epinephrine; repeated administration of nebulized epinephrine may be necessary. Intensive care support should be considered if there is an insufficient response. The effect of nebulized epinephrine lasts for only 1 to 2 hours. 190 After that, clinical symptoms can return to baseline or become more severe (i.e., rebound effect). 186 Children with oxygen saturation below 92% on room air should be given supplemental oxygen. Several reports have described the use of heliox in treating croup with some promising results. [199] [200] [201] However, two Cochrane reviews concluded that there was insufficient evidence to support its use in this setting. 202, 203 The use of antitussive and decongestant agents is not recommended. 152, 186 Treatment with antibiotics is not indicated unless clinical features or laboratory test results indicate a secondary bacterial infection. 152, 173, 186 In cases of severe croup caused by influenza A or B virus, treatment with neuraminidase inhibitors should be considered, although there are insufficient efficacy data for this approach in this setting. 152, [202] [203] [204] [205] [206] Complications and Prognosis. Few patients with croup require intubation and ventilation. 153, 154 Contiguous spread of the viral infection can occur and can cause otitis media, bronchiolitis, or pneumonia. Bacterial superinfection can lead to bacterial tracheitis (discussed later) or bronchopneumonia. The prognosis for uncomplicated croup is very good. Symptoms largely resolve within 48 to 72 hours in most patients. 172 A fatal outcome is very rare. Isolated, acute laryngitis is primarily a disease described in adolescents and adults. Etiologic Agents. Acute laryngitis is caused most commonly by viruses; the spectrum of causative agents is similar to that for croup. [207] [208] [209] [210] [211] Bacteria implicated in acute laryngitis include S. pneumoniae, H. influenzae, and M. catarrhalis. [212] [213] [214] The key features of acute laryngitis are a change in the normal pitch of the voice and hoarseness, which typically last for 3 to 7 days. Coexistence of nonspecific upper respiratory tract infection symptoms, such as coryza, sore throat, and cough, is common. cephalosporin (e.g., ceftriaxone, cefotaxime) and a penicillinase-resistant penicillin (e.g., cloxacillin, nafcillin) given intravenously is a suitable choice in areas where community-acquired MRSA infections are unlikely. Otherwise, vancomycin should replace the latter component. Goodquality evidence is lacking, but many centers use systemic corticosteroids in the first few days of the illness with the intention to reduce airway edema. Most patients require ventilatory support for only 2 to 5 days unless complications occur. The optimal duration of antibiotic treatment is unknown, but most experts recommend a minimum of 10 days of treatment. Complications and Prognosis. Complications of bacterial tracheitis include pneumothorax, pneumomediastinum, pulmonary edema, acute respiratory distress syndrome, hypotension, and cardiorespiratory arrest. 230, 223, 234, 238 Cases with concurrent toxic shock syndrome have been described. 230, 232, 239 Neurologic sequelae are common in patients who experience cardiorespiratory arrest. Subglottic stenosis and subglottic polyps are rare long-term sequelae. 230, 240 Bacterial tracheitis is a potentially life-threatening condition, with some early publications reporting case fatalities in excess of 20%. 230, 238 Fatal outcomes have been uncommon in the past decade, likely reflecting improvements in intensive care support. 125, 220, 221 Acute bronchitis predominately occurs in adolescents and adults. Data from the US National Health Interview Survey suggest that approximately 5% of all adults experience one or more episodes of bronchitis per year. 241 The incidence peaks in autumn and winter. 242 Etiologic Agents. Most cases of bronchitis are nonbacterial in nature, although no causative organism can be identified in many patients. Viral infections appear to account for most cases. 243, 244 Viruses commonly implicated in acute bronchitis include influenza virus, parainfluenza virus, respiratory syncytial virus, rhinovirus, adenovirus, and human metapneumovirus. [243] [244] [245] [246] [247] [248] Infection due to bacterial organisms, including Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae, is less common. [243] [244] [245] Clinical Manifestations and Management. Illness typically begins with nonspecific upper respiratory tract infection symptoms, which usually last for a few days. This is followed by a second phase characterized by persistent cough, frequently with sputum production or wheezing, which typically lasts for 1 to 3 weeks. 242, 243 Antibiotic therapy is not routinely indicated for previously healthy people with acute bronchitis. 242, 249 A Cochrane review that included nine RCTs showed that antibiotic treatment on average reduced the duration of cough by less than 1 day compared with placebo; adverse effects were significantly more common in the antibiotic-treated patients. 250 The update of this review, which included 17 RCTs, concluded that the benefits of antibiotic treatment in bronchitis were marginal. 251, 252 Guidelines for treating acute bronchitis by the American College of Physicians and the American College of Chest Physicians have discouraged the routine use of antibiotics, inhaled bronchodilators, or mucolytic agents. 253, 254 However, patients diagnosed with pertussis should receive azithromycin, primarily to limit transmission. 242 Herzon FS, Martin AD. Medical and surgical treatment of peritonsillar, retropharyngeal, and parapharyngeal abscesses Microbiology and management of deep facial infections and Lemierre syndrome Changing epidemiology of life-threatening upper airway infections: the reemergence of bacterial tracheitis Epiglottitis in the United States: national trends, variances, prognosis, and management The effectiveness of glucocorticoids in treating croup: meta-analysis Nebulized epinephrine for croup in children Bacterial tracheitis: a multi-centre perspective Antibiotics for acute bronchitis Demographics of pediatric head and neck infections in a tertiary care hospital Aerobic and anaerobic microbiology of peritonsillar abscess Variations in the microbiology of peritonsillar abscess Bacteriologic findings in peritonsillar abscesses in young adults The microbiology of peritonsillar sepsis Microbiological features and pathogenesis of peritonsillar abscesses Peritonsillar and neck abscesses in the pediatric age group Peritonsillar abscess in children in the southern district of Israel Incidence, microbiology and clinical history of peritonsillar abscesses Microarray identification of bacterial species in peritonsillar abscesses Suspected peritonsillar abscess in children Changing trends of peritonsillar abscess Peritonsillar abscess in children: a 10-year review of diagnosis and management Needle aspiration of peritonsillar abscess in children Staphylococcus aureus peritonsillar abscess in an 11-week old infant Peritonsillar abscess in a 2 1/2-month-old infant Peritonsillar abscess in an infant Pathogenesis of peritonsillar abscess Peritonsillar infections: local experience Diagnosis of peritonsillar infections: a prospective study of ultrasound, computerized tomography and clinical diagnosis Intraoral ultrasound in the diagnosis and treatment of suspected peritonsillar abscess in the emergency department The use of ultrasound evaluation in the diagnosis of peritonsillar abscess Randomized trial comparing intraoral ultrasound to landmark-based needle aspiration in patients with suspected peritonsillar abscess National audit of the management of peritonsillar abscess An evidence-based review of the treatment of peritonsillar abscess Treatment of peritonsillar abscess. A prospective study of aspiration vs incision and drainage A randomized trial for outpatient management of peritonsillar abscess Management of peritonsillar abscess Trends in the management of pediatric peritonsillar abscess infections in the U.S Microbiology and management of peritonsillar, retropharyngeal, and parapharyngeal abscesses Head and neck space infections in infants and children Peritonsillar abscess The microbiology and antibiotic treatment of peritonsillar abscesses Out-patient management of patients with a peritonsillar abscess Medical and surgical treatment of peritonsillar, retropharyngeal, and parapharyngeal abscesses Controversies in the management of acute tonsillitis: an evidence-based review Use of steroids in the treatment of peritonsillar abscess Retropharyngeal abscess in children: the emerging role of group A beta hemolytic Streptococcus Microbiology of retropharyngeal abscesses in children Bacteriology of retropharyngeal abscess in children Clinical features and treatment of retropharyngeal abscess in children Indicators of a more complicated clinical course for pediatric patients with retropharyngeal abscess Surgical management of retropharyngeal space infections in children Retropharyngeal abscess in children: clinical presentation, utility of imaging, and current management Retropharyngeal and parapharyngeal infections in children: the Toronto experience Parapharyngeal and retropharyngeal infections in children: argument for a trial of medical therapy and intraoral drainage for medical treatment failures Age-, site-, and time-specific differences in pediatric deep neck abscesses Acute cervical lymphadenitis and infections of the retropharyngeal and parapharyngeal spaces in children Staphylococcus aureus retropharyngeal abscess in children Retropharyngeal abscess: epiglottitis of the new millennium Deep neck infections in different age groups of children Retropharyngeal and parapharyngeal abscess in children-epidemiology, clinical features and treatment Pediatric retropharyngeal abscesses: a national perspective Retropharyngeal abscess in children: 10-year study The rising rate of admissions for tonsillitis and neck space abscesses in England Retropharyngeal abscesses: a clinical and radiologic correlation Diagnosis and management decisions in infections of the deep fascial spaces of the head and neck utilizing computerized tomography Computed tomography in the diagnosis of deep-neck infections Correlation between computed tomography and surgical findings in retropharyngeal inflammatory processes in children Deep space neck infection: principles of surgical management Retropharyngeal abscess management in children: current practices Prediction of deep neck abscesses by contrast-enhanced computerized tomography in 76 clinically suspect consecutive patients Piperacillin/tazobactam in the treatment of polymicrobial infections Paediatric retropharyngeal abscess Nonsurgical management of deep neck infections in children Conservative treatment of retropharyngeal and parapharyngeal abscess in children Is conservative treatment of deep neck space infections appropriate? A prospective study of 113 deep neck infections managed using a clinical practice guideline Deep neck infections in children: a new approach to diagnosis and treatment Characterizations of life-threatening deep cervical space infections: a review of one hundred ninety-six cases Parapharyngeal abscess: diagnosis and treatment Clinical infections and nonsurgical treatment of parapharyngeal space infections complicating throat infection Redefining parapharyngeal space infections Parapharyngeal abscess in children: five year retrospective study Nonsurgical management of parapharyngeal space infections: a prospective study PART II Clinical Syndromes and Cardinal Features of Infectious Diseases: Approach to Diagnosis and Initial Management 76 Parapharyngeal abscess in children: the role of CT for diagnosis and treatment Parapharyngeal abscess: diagnosis, complications and management in adults Parapharyngeal abscesses Use of intraoperative ultrasound for localizing difficult parapharyngeal space abscesses in children Intraoral drainage: recommended as the initial approach for the treatment of parapharyngeal abscesses Pharyngomaxillary space abscess with carotid artery erosion Mediastinitis and bilateral pyopneumothorax complicating a parapharyngeal abscess Sur une septico-pyohemie de l'homme simulant la peste et causee par un streptobacille anaerobie Über die Pathogenität anaerober Bazillen On certain septicaemias due to anaerobic organisms The Lemierre syndrome: suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection The evolution of Lemierre syndrome: report of 2 cases and review of the literature Lemierre syndrome: a pediatric case series and review of literature Microbiology and management of deep facial infections and Lemierre syndrome Fusobacterium necrophorum middle ear infections in children and related complications: report of 25 cases and literature review Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers Fusobacterium necrophorum infections in England and Wales 1990-2000 Lemierre's and Lemierre's-like syndromes in children: survival and thromboembolic outcomes Lemierre's syndrome in adolescent children-anaerobic sepsis with internal jugular vein thrombophlebitis following pharyngitis A severe case of Lemierre syndrome with Streptococcus constellatus infection Incidence and clinical epidemiology of necrobacillosis, including Lemierre's syndrome Increased diagnosis of Lemierre syndrome and other Fusobacterium necrophorum infections at a Children's Hospital Lemierre syndrome Lemierre syndrome in a 5-month-old male infant: case report and review of the pediatric literature Necrobacillosis in Great Britain Septic thrombosis of the internal jugular vein: Lemierre's syndrome revisited Necrobacillosis: a forgotten disease Suppurative thrombophlebitis of the internal jugular vein Fusobacterium necrophorum septicemia following oropharyngeal infection Lemierre syndrome with meningo-encephalitis, severe cerebral artery stenosis, and focal neurological symptoms The spectrum of fusobacterial infections in children Lemierre syndrome complicating otitis externa: case report and literature review Human necrobacillosis, with emphasis on Lemierre's syndrome Lemierre's syndrome: three cases and a review Lemierre's syndrome Lemierre syndrome: forgotten but not extinct-report of four cases Lemierre syndrome: usefulness of CT in detection of extensive occult thrombophlebitis Current management of upper respiratory tract and head and neck infections Lemierre's syndrome: a potentially fatal complication that may require vascular surgical intervention A case of Lemierre syndrome and the role of modern antibiotics and therapeutic anticoagulation in its treatment Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada Epiglottitis in the Hemophilus influenzae type B vaccine era: changing trends Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme Paediatric acute epiglottitis: not a disappearing entity Decreases in invasive Haemophilus influenzae diseases in US Army children Epiglottitis in Sweden before and after introduction of vaccination against Haemophilus influenzae type b Changing epidemiology of life-threatening upper airway infections: the reemergence of bacterial tracheitis The dramatic change in the epidemiology of pediatric epiglottitis Paediatric airway emergencies in Northern Ireland Invasive infections caused by Haemophilus influenzae serotypes in twelve Canadian IMPACT centers Acute epiglottitis: epidemiology, clinical presentation, management and outcome Invasive Haemophilus influenzae type b disease in England and Wales: who is at risk after 2 decades of routine childhood vaccination? Necrotizing epiglottitis in an infant: an unusual first presentation of human immunodeficiency virus infection Treatment of Haemophilus influenzae type B epiglottitis Haemophilus influenzae type b epiglottitis as a cause of acute upper airways obstruction in children Acute epiglottitis despite vaccination with Haemophilus influenzae type B vaccine Acute epiglottitis after Hib vaccination Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood Acute epiglottitis. An 18-year experience in Rhode Island Group A streptococcal supraglottitis Group A streptococcal supraglottitis The rising incidence of adult acute epiglottitis and epiglottic abscess The burden of epiglottitis among Japanese children before the Haemophilus influenzae type b vaccination era: an analysis using a nationwide administrative database Changes in the epidemiology of epiglottitis following introduction of Haemophilus influenzae type b (Hib) conjugate vaccines in England: a comparison of two data sources Epiglottitis in the United States: national trends, variances, prognosis, and management Airway management in pediatric epiglottitis: a national perspective Epiglottitis and Haemophilus influenzae immunization: the Pittsburgh experience-a five-year review Adult epiglottitis in a Canadian setting Diagnosis and management of croup and epiglottitis Pharyngitis and epiglottitis Haemophilus influenzae infections Revised recommendations for prevention of secondary Haemophilus influenzae type b (Hib) disease Clinical practice. Croup Clinical courses of croup caused by influenza and parainfluenza viruses Aetiology and epidemiology of viral croup in Glasgow, 1966-72 Lower respiratory tract illness in the first two years of life: epidemiologic patterns and costs in a suburban pediatric practice Croup: an 11-year study in a pediatric practice Viral etiology and epidemiology of acute lower respiratory tract infections in Korean children Incidence and etiology of pneumonia, croup and bronchiolitis in preschool children belonging to a prepaid medical care group over a four-year period Viral etiologies of infant bronchiolitis, croup and upper respiratory illness during 4 consecutive years Role of human coronavirus NL63 in hospitalized children with croup The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children Detection of human bocavirus in Canadian children in a 1-year study Prospective study of human bocavirus (HBoV) infection in a pediatric university hospital in Germany Croup is associated with the novel coronavirus NL63 Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children Respiratory viruses in laryngeal croup of young children The viral aetiology of croup and recurrent croup Croup presentations to emergency departments in Alberta, Canada: a large population-based study Weather factors associated with paediatric croup presentations to an Australian emergency department Fibrinous laryngotracheobronchitis in children The management of acute croup Croup in the paediatric emergency department Congenital vascular anomalies and persistent respiratory symptoms in children Acquired upper airway obstruction Croup: diphtheria: tracheotomy A Lecture on the relation between croup and diphtheria The assessment and management of croup Evidence based guideline for the management of croup Humidification in viral croup: a controlled trial A randomized controlled trial of mist in the acute treatment of moderate croup The effect of humidified air in mild to moderate croup: evaluation using croup scores and respiratory inductance plethysmography (RIP) Controlled delivery of high vs low humidity vs mist therapy for croup in emergency departments: a randomized controlled trial Humidified air inhalation for treating croup Glucocorticoids for croup Croup-treatment update The effectiveness of glucocorticoids in treating croup: meta-analysis A randomized trial of a single dose of oral dexamethasone for mild croup Croup in children Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study Inhalation of racemic adrenaline in the treatment of mild and moderately severe croup. Clinical symptom score and oxygen saturation measurements for evaluation of treatment effects Racemic epinephrine in the treatment of croup: nebulization alone versus nebulization with intermittent positive pressure breathing Treatment of acute viral croup Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup) Safety and efficacy of nebulized racemic epinephrine in conjunction with oral dexamethasone and mist in the outpatient treatment of croup Ten-year experience with IPPB in the treatment of acute laryngotracheobronchitis Nebulized epinephrine for croup in children The safety of nebulization with 3 to 5 ml of adrenaline (1:1000) in children: an evidence based review The effect of heliox on croup: a pilot study A randomized comparison of heliumoxygen mixture (Heliox) and racemic epinephrine for the treatment of moderate to severe croup Heliox treatment of severe croup Heliox for croup in children Heliox for croup in children Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) Neuraminidase inhibitors for preventing and treating influenza in children Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials Laryngitis: types, causes, and treatments Outbreak of human metapneumovirus infection in norwegian children Otitis and respiratory distress episodes following a respiratory syncytial virus infection Serological diagnosis of respiratory viral infections. A five-year study of hospitalised patients Clinical evaluation of radioimmunoassay of nasopharyngeal secretions and serology for diagnosis of viral infections in children hospitalized for respiratory infections Moraxella catarrhalis in acute laryngitis: infection or colonization? Moraxella catarrhalis: from emerging to established pathogen High isolation rate of Branhamella catarrhalis from the nasopharynx in adults with acute laryngitis Antibiotics for acute laryngitis in adults Acute laryngotracheobronchitis Acute laryngotracheobronchitis Bacterial tracheitis-tremendously rare, but truly important: a systematic review Bacterial tracheitis: a multi-centre perspective Bacterial tracheitis reexamined: is there a less severe manifestation? Airway endoscopy in the diagnosis and treatment of bacterial tracheitis in children Pseudomembranous tracheobronchitis due to Bacillus cereus PART II Clinical Syndromes and Cardinal Features of Infectious Diseases: Approach to Diagnosis and Initial Management 225. Brook I. Aerobic and anaerobic microbiology of bacterial tracheitis in children Aerobic and anaerobic microbiology of bacterial tracheitis in children Pseudomembranous tracheobronchitis caused by methicillin-resistant Staphylococcus aureus Bacterial tracheitis in adults Case report: bacterial tracheitis in an adult female Bacterial tracheitis in children Bacterial tracheitis Systemic complications associated with bacterial tracheitis Extracorporeal membrane oxygenation for refractory air leak in a child presenting with bacterial tracheitis Bacterial tracheitis-an old disease rediscovered Is bacterial tracheitis changing? A 14-month experience in a pediatric intensive care unit Bacterial tracheitis: report of eight new cases and review Bacterial tracheitis, diagnosis and treatment Bacterial tracheitis Toxic shock syndrome as a complication of bacterial tracheitis Bacterial tracheitis among children hospitalized for severe obstructive dyspnea Current estimates from the National Health Interview Survey Clinical practice. Acute bronchitis Management of acute bronchitis in healthy adults Reversible airflow limitation in adults with respiratory infection Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study Respiratory syncytial virus infection in adults Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients Uncomplicated acute bronchitis Antibiotics for acute bronchitis Antibiotics for acute bronchitis Antibiotics for acute bronchitis Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines The authors wish to acknowledge the use of figures and legends (Figs. 28.1, 28.3, and 28.4), contributed by Richard H. Schwartz from the third edition.All references are available online at www.expertconsult.com.